Skip to main content
Premium Trial:

Request an Annual Quote

German Proteomics Firm MelTec Wins 2.3M Government Grant

NEW YORK, July 9 - German proteomics firm MelTec said today it has secured a €2.3 million government grant to create a multi-disciplinary research group to study protein network hierarchies in cells.


The company will use the grant, provided by the German Federal Ministry for Education, Science, Research, and Technology, to establish the group, called CELLECT, which stands for cellular eukaryotic proteome code-deciphering technology.


According to MelTec, this group, a "multi-disciplinary" network of 10 research groups that includes a unit of the Max Planck Institute, hopes to develop a "machine" that can decipher protein network hierarchies in cells, which in turn might help drug development.


MelTec, based in Magdeburg, is privately held.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.